Generally Unacceptable Accounting Principles: Lessons From PwC and AstraZeneca’s Contrasting Fates
The Asian Crime Century briefing 99
The pharmaceutical company AstraZeneca had good news from the People’s Republic of China (PRC) at the end of November, with the National Healthcare Security Administration (国家医疗保障局) pre-approving its cancer drug Enhertu for the national health insurance reimbursement list (SCMP, November 29). This news will be welcomed, as the company…